Abiopharma

AGF Management Limited to Release Third Quarter 2025 Financial Results on September 24, 2025

AGF Reports August 2025 Assets Under Management and Fee-Earning Assets

AGF déclare le total de son actif géré et de ses actifs donnant droit à des commissions pour août 2025

Ramaswamy Vivek 🔴 sold 1.8M shares of Roivant Sciences Ltd. (ROIV) at $12.96 ($22.5M) Transaction Date: Sep 03, 2025 | Filing ID: 000007

New Form SCHEDULE 13D/A - STRATA Skin Sciences, Inc. Filed: 2025-09-05 AccNo: 0001213900-25-085116 Size: 13 KB

New Form 3 - Sintx Technologies, Inc. Filed: 2025-09-05 AccNo: 0001493152-25-012751 Size: 5 KB

New Form SCHEDULE 13G/A - UTAH MEDICAL PRODUCTS INC Filed: 2025-09-05 AccNo: 0001041062-25-000177 Size: 6 KB

Elsbernd Brian 🟡 adjusted position in 50.0K shares (2 derivative) of CATALYST PHARMACEUTICALS, INC. (CPRX) at $20.08 ($1.2M) Transaction Date: Sep 03, 2025 | Filing ID: 000318

Chijet Motor Company Inc. Announces Issuance of Ordinary Shares to Holders of Contingent Value Rights

Full Circle Lithium Announces Closing of C$4.5 Million Private Placement

Larson-Green Julie 🟢 acquired 4.6K shares of Health Catalyst, Inc. (HCAT) Transaction Date: Sep 01, 2025 | Filing ID: 006121

Gallagher Duncan 🟢 acquired 5.0K shares of Health Catalyst, Inc. (HCAT) Transaction Date: Sep 01, 2025 | Filing ID: 006120

New Form 424B5 - BRUKER CORP Filed: 2025-09-05 AccNo: 0001140361-25-034214 Size: 1 MB

New Form 424B5 - USBC, Inc. Filed: 2025-09-05 AccNo: 0001654954-25-010448 Size: 19 KB

New Form 8-K - Praxis Precision Medicines, Inc. Filed: 2025-09-05 AccNo: 0001104659-25-087865 Size: 510 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits